Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia–telangiectasia:

Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia–telangiectasia: Ataxia–telangiectasia confers a significant increase in the development of several cancer types, most commonly leukemia and lymphoma. However, as the natural history for these patients is evolving and their lifespan is increasing, there is the potential for the development of additional uncommon tumors in an already rare patient population. We report the first case, to our knowledge, of an incidental retroperitoneal tumor in a 26-year-old woman undergoing evaluation for hepatic dysfunction. The mass was suspicious for retroperitoneal sarcoma, but proved to be an extramedullary hematopoietic pseudotumor after extensive pathologic evaluation. The changing landscape of neoplasms associated with ataxia–telangiectasia is discussed with emphasis on previously underreported benign and malignant tumors. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Rare Tumors SAGE

Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia–telangiectasia:

Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia–telangiectasia:

Rare Tumors , Volume 10: 1 – Jul 22, 2018

Abstract

Ataxia–telangiectasia confers a significant increase in the development of several cancer types, most commonly leukemia and lymphoma. However, as the natural history for these patients is evolving and their lifespan is increasing, there is the potential for the development of additional uncommon tumors in an already rare patient population. We report the first case, to our knowledge, of an incidental retroperitoneal tumor in a 26-year-old woman undergoing evaluation for hepatic dysfunction. The mass was suspicious for retroperitoneal sarcoma, but proved to be an extramedullary hematopoietic pseudotumor after extensive pathologic evaluation. The changing landscape of neoplasms associated with ataxia–telangiectasia is discussed with emphasis on previously underreported benign and malignant tumors.

Loading next page...
 
/lp/sage/retroperitoneal-extramedullary-hematopoietic-pseudotumor-in-ataxia-SCiOeszki3

References (20)

Publisher
SAGE
Copyright
Copyright © 2022 by SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
ISSN
2036-3613
eISSN
2036-3613
DOI
10.1177/2036361318789724
Publisher site
See Article on Publisher Site

Abstract

Ataxia–telangiectasia confers a significant increase in the development of several cancer types, most commonly leukemia and lymphoma. However, as the natural history for these patients is evolving and their lifespan is increasing, there is the potential for the development of additional uncommon tumors in an already rare patient population. We report the first case, to our knowledge, of an incidental retroperitoneal tumor in a 26-year-old woman undergoing evaluation for hepatic dysfunction. The mass was suspicious for retroperitoneal sarcoma, but proved to be an extramedullary hematopoietic pseudotumor after extensive pathologic evaluation. The changing landscape of neoplasms associated with ataxia–telangiectasia is discussed with emphasis on previously underreported benign and malignant tumors.

Journal

Rare TumorsSAGE

Published: Jul 22, 2018

Keywords: Extramedullary hematopoietic pseudotumor; retroperitoneal sarcoma; ataxia–telangiectasia

There are no references for this article.